Catheter Precision Statistics
Total Valuation
VTAK has a market cap or net worth of $2.11 million. The enterprise value is $13.66 million.
Important Dates
The last earnings date was Monday, May 18, 2026, before market open.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VTAK has 2.69 million shares outstanding. The number of shares has increased by 376.73% in one year.
| Current Share Class | 2.69M |
| Shares Outstanding | 2.69M |
| Shares Change (YoY) | +376.73% |
| Shares Change (QoQ) | +29.27% |
| Owned by Insiders (%) | 14.97% |
| Owned by Institutions (%) | 6.51% |
| Float | 2.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| Forward PS | 0.20 |
| PB Ratio | 0.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06, with a Debt / Equity ratio of 1.31.
| Current Ratio | 0.06 |
| Quick Ratio | 0.04 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.46 |
Financial Efficiency
Return on equity (ROE) is -179.70% and return on invested capital (ROIC) is -44.88%.
| Return on Equity (ROE) | -179.70% |
| Return on Assets (ROA) | -23.05% |
| Return on Invested Capital (ROIC) | -44.88% |
| Return on Capital Employed (ROCE) | -71.96% |
| Weighted Average Cost of Capital (WACC) | 2.87% |
| Revenue Per Employee | $65,176 |
| Profits Per Employee | -$951,706 |
| Employee Count | 17 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | -1.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.54% in the last 52 weeks. The beta is 0.32, so VTAK's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -85.54% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.97 |
| Relative Strength Index (RSI) | 37.57 |
| Average Volume (20 Days) | 118,140 |
Short Selling Information
The latest short interest is 37,414, so 1.39% of the outstanding shares have been sold short.
| Short Interest | 37,414 |
| Short Previous Month | 42,085 |
| Short % of Shares Out | 1.39% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, VTAK had revenue of $1.11 million and -$16.18 million in losses. Loss per share was -$10.94.
| Revenue | 1.11M |
| Gross Profit | 1.01M |
| Operating Income | -11.04M |
| Pretax Income | -16.60M |
| Net Income | -16.18M |
| EBITDA | -9.05M |
| EBIT | -11.04M |
| Loss Per Share | -$10.94 |
Full Income StatementBalance Sheet
The company has $441,000 in cash and $11.99 million in debt, with a net cash position of -$11.55 million or -$4.29 per share.
| Cash & Cash Equivalents | 441,000 |
| Total Debt | 11.99M |
| Net Cash | -11.55M |
| Net Cash Per Share | -$4.29 |
| Equity (Book Value) | 9.16M |
| Book Value Per Share | 3.55 |
| Working Capital | -18.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.75 million and capital expenditures -$13,000, giving a free cash flow of -$8.77 million.
| Operating Cash Flow | -8.75M |
| Capital Expenditures | -13,000 |
| Depreciation & Amortization | 1.99M |
| Net Borrowing | 834,000 |
| Free Cash Flow | -8.77M |
| FCF Per Share | -$3.26 |
Full Cash Flow StatementMargins
| Gross Margin | 91.52% |
| Operating Margin | -996.66% |
| Pretax Margin | -1,498.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VTAK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -376.73% |
| Shareholder Yield | -376.73% |
| Earnings Yield | -767.43% |
| FCF Yield | -415.85% |
Analyst Forecast
The average price target for VTAK is $38.00, which is 4,753.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 4,753.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 15, 2025. It was a reverse split with a ratio of 1:19.
| Last Split Date | Aug 15, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:19 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
